| Predicate |
Object |
| contentType |
Comparative Study|Journal Article|Review |
| endingPage |
100 |
| issn |
0012-6667
1179-1950 |
| issueIdentifier |
1 |
| pageRange |
85-100 |
| publicationName |
Drugs |
| startingPage |
85 |
| bibliographicCitation |
van 't Hof AW, Valgimigli M. Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban. Drugs. 2009;69(1):85–100. doi: 10.2165/00003495-200969010-00006. PMID: 19192938. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9aa90be3e5bcc06ccac4021850f97dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3315f933b8577e6212ec071a81731d6f |
| date |
200901 |
| identifier |
https://doi.org/10.2165/00003495-200969010-00006
https://pubmed.ncbi.nlm.nih.gov/19192938 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1179-1950
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/0012-6667 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban |
| discusses |
http://id.nlm.nih.gov/mesh/M0022203
http://id.nlm.nih.gov/mesh/M0227707
http://id.nlm.nih.gov/mesh/M0028424
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0211213
http://id.nlm.nih.gov/mesh/M0011126
http://id.nlm.nih.gov/mesh/M0017012 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947 |